125th MAINE LEGISLATURE
		LD 719		LR 1590(02)
	An Act To Make Certain Prescription Drug Disclosure Laws Consistent with Federal Law
	Fiscal Note for Bill as Amended by Committee Amendment "   "
	Committee: Health and Human Services
	Fiscal Note Required: Yes
Fiscal Note
Potential current biennium cost increase - General Fund
			FY 2011-12	FY 2012-13	Projections  FY 2013-14	Projections  FY 2014-15
Appropriations/Allocations
	Other Special Revenue Funds		($223,000)	($223,000)	($223,000)	($223,000)
Revenue
	Other Special Revenue Funds		($223,000)	($223,000)	($223,000)	($223,000)
Fiscal Detail and Notes
	The bill as amended would make changes to existing Maine prescription drug disclosure laws that the Department of Health and Human Services believes have helped it offset federal reductions in drug rebates for the MaineCare and other prescription drug programs.  Eliminating these provisions could result in a reduction of these rebates and a net increase in program costs, the exact amount of which cannot be determined at this time.  Also assumes a reduction in funding as a result of reduction in the drug trial and drug marketing programs and fees that are partially offset by the restoration of a $500 fee for the drug academic detailing program.